DxS acquires exclusive licence for key PI3K gene from Johns Hopkins University
Wednesday, February 10, 2010 14:00 IST Venlo, The Netherlands
QIAGEN announced that its wholly owned subsidiary DxS has acquired the global and exclusive licence for biomarker PI3K from Johns Hopkins University to develop real-time-PCR and endpoint PCR assays.